Pamnani M B, Chen X, Haddy F J, Schooley J F, Mo Z
Department of Physiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 USA.
Clin Exp Hypertens. 2000 Aug;22(6):555-69. doi: 10.1081/ceh-100100091.
Dietary potassium supplementation lowers blood pressure (BP) and attenuates complications in hypertensive subjects, particularly those with the low renin volume expanded (LRVE) variety. We and others have shown that the plasma level of a digitalis like substance (DLS) is elevated in this type of hypertension. We therefore, examined the effect of increases in dietary potassium on the plasma level of endogenous DLS, myocardial and renal Na+, K+-ATPase (NKA) activities, BP, and renal excretory function in reduced renal mass (RRM)-salt hypertension in the rat, a classical model of LRVE hypertension. 70% RRM rats were divided in 4 groups, namely those consuming: 1) a sodium free and normal potassium (1.3% as KCl) diet (RRM-0 Na), 2) a normal sodium and normal potassium diet (RRM-NaK), 3) a normal sodium and high potassium (2 X normal) diet (RRM-Na2K), and 4) a normal sodium and 4 times normal potassium diet (RRM-Na4K). At the end of 4 weeks of dietary treatment, direct BP was recorded, plasma level of DLS determined by bioassay and with a radioimmunoassay for digoxin (DIF) and myocardial and renal NKA activities were measured. As expected, compared to RRM-0Na rats, RRM-NaK rats developed hypertension. BP increased significantly less in RRM-Na2K, whereas BP did not increase in RRM-Na4K rats. Hypertension in RRM-NaK rats was associated with an increase in plasma DLS and DIF and decrease in renal and myocardial NKA activities. DLS was increased (DIF was not changed) and myocardial NKA also decreased in rats consuming double potassium. However, quadrupling potassium in the diet (RRM-Na4K) normalized DLS and DIF and increased myocardial and renal NKA activities, compared to RRM-0Na rats. Also compared to RRM-0Na, water consumption, urinary volume excretion, sodium, and potassium increased in the other 3 groups, more so in RRM-Na4K rats. These data show that quadrupling the potassium in the diet prevents the BP increase in RRM rats and this is associated with diuresis/natriuresis and normalization of DLS, perhaps because the diuresis/natriuresis normalizes blood volume.
膳食补钾可降低高血压患者的血压(BP)并减轻并发症,尤其是低肾素容量扩张型(LRVE)的患者。我们和其他人已经表明,在这种类型的高血压中,洋地黄样物质(DLS)的血浆水平会升高。因此,我们研究了增加膳食钾对大鼠肾质量减少(RRM)-盐高血压模型(LRVE高血压的经典模型)中内源性DLS的血浆水平、心肌和肾脏钠钾ATP酶(NKA)活性、血压和肾脏排泄功能的影响。70%肾切除大鼠分为4组,即食用:1)无钠和正常钾(1.3%以氯化钾形式)饮食的大鼠(RRM-0Na),2)正常钠和正常钾饮食的大鼠(RRM-NaK),3)正常钠和高钾(2倍正常量)饮食的大鼠(RRM-Na2K),以及4)正常钠和4倍正常钾饮食的大鼠(RRM-Na4K)。在饮食治疗4周结束时,记录直接血压,通过生物测定法测定DLS的血浆水平,并使用地高辛放射免疫测定法(DIF)测定,同时测量心肌和肾脏的NKA活性。正如预期的那样,与RRM-0Na大鼠相比,RRM-NaK大鼠出现了高血压。RRM-Na2K大鼠的血压升高明显较少,而RRM-Na4K大鼠的血压没有升高。RRM-NaK大鼠的高血压与血浆DLS和DIF增加以及肾脏和心肌NKA活性降低有关。食用双倍钾的大鼠DLS增加(DIF未改变)且心肌NKA也降低。然而,与RRM-0Na大鼠相比,饮食中钾含量增加四倍(RRM-Na4K)使DLS和DIF恢复正常,并增加了心肌和肾脏的NKA活性。与RRM-0Na相比,其他3组的饮水量、尿量排泄、钠和钾也增加,RRM-Na4K大鼠增加得更多。这些数据表明,饮食中钾含量增加四倍可防止RRM大鼠血压升高,这与利尿/利钠以及DLS正常化有关,可能是因为利尿/利钠使血容量正常化。